Literature DB >> 16823061

PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.

E Goshen1, T Davidson, D Aderka, S T Zwas.   

Abstract

Abdominal wall metastases from colorectal cancer (CRC) may be resected with curative results. Such lesions, often indicators of additional intra-abdominal lesions, may appear in surgical scars, stomas and port site metastases after laparoscope-assisted surgery (LAS). Post-operative changes, primarily surgical scars, alter local physical findings making early detection of small lesions challenging. The purpose of this study was to retrospectively evaluate the contribution of PET/CT to the diagnosis of recurrent colorectal cancer in the post-operative abdominal wall. 120 patients were referred for PET/CT with suspected recurrent CRC based on clinical, radiological or laboratory findings. All underwent whole body PET/CT imaging. 12 of these 120 (10%), were found to have abdominal wall lesions. A total of 16 abdominal wall lesions were detected, located to surgical scars, stomas, drain and laparoscope ports. Additional findings on PET/CT in this group included liver metastases, intra-abdominal lesions and retroperitoneal lymph node involvement. In general, the patients in this small group were young with high grade tumours presenting in advanced stages. In conclusion, PET/CT appears to be a sensitive tool for the diagnosis of abdominal wall recurrence of CRC. The accuracy of localization afforded by the fused functional and anatomic images makes PET/CT a likely tool for diagnosing abdominal wall lesions, including port site metastases of other aetiologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823061     DOI: 10.1259/bjr/25287790

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Postoperative changes after surgical mesh hernia repair: a pitfall in interpretation of 18F-FDG PET-CT.

Authors:  T Davidson; E Klang; E Goshen; J Goldstein; M Khaikin; B Chikman; S Ben-Haim
Journal:  Hernia       Date:  2017-04-06       Impact factor: 4.739

2.  Fat necrosis after abdominal surgery: A pitfall in interpretation of FDG-PET/CT.

Authors:  Tima Davidson; Eyal Lotan; Eyal Klang; Johnatan Nissan; Jeffrey Goldstein; Elinor Goshen; Simona Ben-Haim; Sara Apter; Bar Chikman
Journal:  Eur Radiol       Date:  2017-12-20       Impact factor: 5.315

3.  A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.

Authors:  Kimihiko Funahashi; Mitsunori Ushigome; Hironori Kaneko
Journal:  World J Surg Oncol       Date:  2011-02-28       Impact factor: 2.754

4.  What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

Authors:  Monique Maas; Iris J G Rutten; Patty J Nelemans; Doenja M J Lambregts; Vincent C Cappendijk; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

5.  Colorectal cancer - patterns of locoregional recurrence and distant metastases as demonstrated by FDG PET / CT.

Authors:  Nilendu C Purandare; Sumeet G Dua; Abhishek Arora; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Radiol Imaging       Date:  2010-11

6.  Anterior abdominal wall metastasis following curative resection and chemoradiation of rectal cancer masquerading as a desmoid tumour: A clinical conundrum.

Authors:  Ajay Raveendranadh; Meera Goutham; Chiranth Gowda; Kshama Hegde; Vidya Monappa; Gabriel Rodrigues
Journal:  J Taibah Univ Med Sci       Date:  2021-09-25

Review 7.  A rare case of isolated wound implantation of colorectal adenocarcinoma complicating an incisional hernia: case report and review of the literature.

Authors:  Aninda Chandra; Lester Lee; Fahad Hossain; Harnaik Johal
Journal:  World J Surg Oncol       Date:  2008-01-17       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.